Sunday, December 21, 2025
ADVT 
National

Nomination for DARPAN Extraordinary Achievement Awards 2022 are now open

Darpan News Desk Darpan, 03 Aug, 2022 09:46 AM
  • Nomination for DARPAN Extraordinary Achievement Awards 2022 are now open

Nomination for DARPAN Extraordinary Achievement Awards 2022 are now open.

DARPAN is excited to announce its 12th Annual DARPAN Extraordinary Achievement Awards which is set to take place on October 7, 2022, in Surrey​​. We come together to celebrate the achievements and extraordinary people of the South Asian community. DARPAN’s Extraordinary Achievement Awards is now recognised as one of the most sought-after events of the year where we aim to bring the movers and shakers of the community together, under one roof.

With Royal Bank of Canada as the presenting sponsor and the support of other valuable and esteemed sponsors, institutions, organisations and individuals, we bring this event to reality, every year. Team Darpan is passionately working towards hosting our esteemed guests and celebrating the community.

This year, ten renowned individuals from the South Asian community will be honoured for their monumental and remarkable achievements in their respective fields. By awarding them the prestigious DARPAN Extraordinary Achievement Award, we celebrate and applaud their great contribution to Canadian society and encourage the spirit of the South Asian community. With over 700 people which includes the top social and business elite in the South Asian community as well as Vancouver’s dignitaries in attendance, this is going to be a night to remember and celebrate extraordinary achievements.

We are glad to announce that the nominations for this year’s DARPAN’s Extraordinary Achievement Awards are now open DARPAN Awards 2022 will take place at Aria Banquet and Convention Centre in Surrey on October 7th, 2022.

If you know someone who deserves this award due to their monumental contribution, nominate them and get him/her closer to being recognised.

To nominate, click on the link below.

Click Here

MORE National ARTICLES

Twitter board to evaluate Musk's 'unsolicited, non-binding' $43B offer

Twitter board to evaluate Musk's 'unsolicited, non-binding' $43B offer
Earlier in the day, Musk made an offer to buy 100 per cent of Twitter at $54.20 per share, a 54 per cent premium over the closing price of Twitter on January 28, 2022, the trading day before Musk began investing in the company. This is a 38 per cent premium over the closing price of Twitter on April 1, 2022, the trading day before Musk's investment in Twitter was publicly announced.

Twitter board to evaluate Musk's 'unsolicited, non-binding' $43B offer

Feds to target need with housing cash, Hussen says

Feds to target need with housing cash, Hussen says
Housing Minister Ahmed Hussen said the budget's plan to double housing starts over the next decade will aim to incentivize the construction of units needed by seniors who are downsizing, for example, as well as newcomer families.

Feds to target need with housing cash, Hussen says

B.C. fires, floods add uncertainty to spring thaw

B.C. fires, floods add uncertainty to spring thaw
Major wildfires, droughts and mudslides last year dramatically altered the landscape, raising questions about the river's ability to handle the spring thaw, or freshet.

B.C. fires, floods add uncertainty to spring thaw

Confirmed outbreak of avian flu in B.C.

Confirmed outbreak of avian flu in B.C.
She says all poultry producers, including backyard poultry owners, are advised to increase their biosecurity practices and carefully monitor their flocks for any sign of illness.

Confirmed outbreak of avian flu in B.C.

Singh demands Indian PM stop anti-Muslim hate

Singh demands Indian PM stop anti-Muslim hate
In an outspoken intervention into Indian politics, Singh says he is deeply concerned by images, videos and targeted threats of violence against the country's Muslim community.    

Singh demands Indian PM stop anti-Muslim hate

Health Canada approves COVID-19 prevention drug

Health Canada approves COVID-19 prevention drug
The drug, named Evusheld, is intended for people who cannot receive a typical vaccine or for whom vaccines alone won't provide enough immunity. AstraZeneca says the drug is not a substitute for vaccination against COVID-19 for most people.    

Health Canada approves COVID-19 prevention drug